Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter for Atrial Fibrillation

Abbott announced U.S. Food and Drug Administration (FDA) approval for its TactiFlex™ Duo Ablation Catheter, Sensor Enabled™, designed to treat challenging cases of atrial fibrillation (AFib). This dual-energy catheter combines pulsed field ablation (PFA) and radiofrequency (RF) energy, offering physicians more flexibility in tailoring treatment.